# Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cardiovascular-safety-and-efficacy-of-the-pcsk9-inhibitor-evolocumab-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marc S. Sabatine,Lawrence A. Leiter,Stephen D. Wiviott,Robert P. Giugliano,Prakash Deedwania,Gaetano Maria De Ferrari,Sabina A. Murphy,Julia Kuder,Ioanna Gouni‐Berthold,Basil S. Lewis,Yehuda Handelsman,Armando Lira Pineda,Narimon Honarpour,Anthony Keech,Peter S. Sever,Terje R. Pedersen |
| Citations | 599 |
| DOI | 10.1016/s2213-8587(17)30313-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10044/1/51972 |
| OpenAlex ID | https://openalex.org/W2754562397 |
| PMID | 28927706 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Marc S. Sabatine](https://scholariq.org/researchers/marc-s-sabatine/)
- [Yehuda Handelsman](https://scholariq.org/researchers/yehuda-handelsman/)
- [Lawrence A. Leiter](https://scholariq.org/researchers/lawrence-a-leiter/)
- [Sabina A. Murphy](https://scholariq.org/researchers/sabina-a-murphy/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.